April 2008
The U.S. Food and Drug Administration (FDA) has granted a CLIA waiver for the QuickVue respiratory syncytial virus (RSV) test manufactured by Quidel (San Diego, Calif.). The test qualitatively detects RSV, the leading cause of pneumonia and bronchiolitis among children two years of age and younger. The test is intended for use as an aid in the diagnosis of acute RSV viral infections for symptomatic pediatric patients.
Subscribers: click here for the full story
 Non-Subscribers: click here to subscribe
|
|
|
Archives
|
|